Article

Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies

2021-09-22

Abstract excerpt

<h4>Objectives</h4> To investigate the association between long term low-dose acetylsalicylic acid (LDASA) use and the development of all-cause dementia, Alzheimer’s disease (AD) and vascular dementia (VD). <h4>Design</h4> Meta-analysis of individual participant data from two prospective cohort studies. <h4>Setting</h4> Community-dwelling older adults from Germany (ESTHER) and United Kingdom (UK Biobank). <h4>Part...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a4183f04-c932-501a-9a67-4770ef7319db
DOI: 10.1101/2021.09.20.21263830

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studiesDOI 10.1101/2021.09.20.21263830Read

Association of regular glucosamine use with incident dementia: evidence from a longitudinal cohort and Mendelian randomization study.Semantic proximity Read

Associations between the use of common nonsteroidal anti-inflammatory drugs, genetic susceptibility and dementia in participants with chronic pain: A prospective study based on 194,758 participants from the UK Biobank.Semantic proximity Read

Association of blood lipids, atherosclerosis and statin use with dementia after strokeSemantic proximity Read

Hormone replacement therapy and dementia risk among postmenopausal women: evidence from the UK BiobankSemantic proximity Read

Medication Exposure and Neurodegenerative Disease Risk Across National BiobanksSemantic proximity Read

Effect of initiating an ARB- versus ACEI-based regimen on dementia risk, a target trial emulation of 2.5 million US VeteransSemantic proximity Read

Habitual glucosamine use, APOE genotypes, and risk of incident cause-specific dementia in the older population.Semantic proximity Read

Geographic variation in dementia-related adverse events associated with sacubitril/valsartan: Analysis of the FDA Adverse Event Reporting SystemSemantic proximity Read

Alzheimer Disease—No Target for Statin Treatment. A Mini ReviewSemantic proximity Read

Association of regular use of ibuprofen and paracetamol, genetic susceptibility, and new-onset dementia in the older population.Semantic proximity Read

Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial.Semantic proximity Read

Treatment effects of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A systematic review overview and updated network meta-analysis.Semantic proximity Read